ZL-2102
/ ZAI Lab, Sanofi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 24, 2019
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects
(clinicaltrials.gov)
- P1; N=120; Active, not recruiting; Sponsor: Zai Lab Pty. Ltd.; Trial completion date: Aug 2017 ➔ Aug 2019
Clinical • Trial completion date
1 to 1
Of
1
Go to page
1